High-dose therapy for treatment of breast cancer

Nurse Practitioner Forum: Current Topics and Communications

Volumn 10, Issue 3, 1999, Pages 154-158

  Anderson Reitz, Lowell ^a   Mechling, Beth E ^a   Hertz, Susan Lasker ^b  

^a ROCKY MOUNTAIN CANCER CENTERS   (United States)

^b HealthOne   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; BREAST TUMOR; CANCER STAGING; ECONOMICS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; MORTALITY; NURSE PRACTITIONER; NURSING; PATHOLOGY; PATIENT SELECTION; REVIEW;

BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM STAGING; NURSE PRACTITIONERS; PATIENT SELECTION;

EID: 0033182219     PISSN: 10455485     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wingo P, Tong T, Bolden S: Cancer statistics. A Cancer Journal for Clinicians 45:8-30, 1995
2. Fisher B, Bauer M, Margolese RE: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985
3. Thomas ED, Storb R: The development of the scientific foundation of hematopoietic cell transplantation based on animal and human studies, in Thomas ED, Blume KG, Forman SJ (eds): Hematopoietic Cell Transplantation. Malden, MA, Blackwell Science, 1999, pp 1-11
4. Thomas E, Lochte HE: Supralethal whole body irradiation and isologous marrow transplantation in man. J Clin Invest 38:1709-1716, 1959
5. Doroshow JH: Pharmacological basis for high-dose chemotherapy, in Thomas ED, Blume KG, Forman SJ (eds): Hematopoietic Cell Transplantation. Maiden, MA, Blackwell Science, 1999, pp 103-134
6. Frie E, Canellos GP: Dose: A critical factor in cancer chemotherapy. Am J Med 89:585-594, 1980
7. Lazarus HM: Hematopoietic progenitor cell transplantation in breast cancer: Current status and future directions. Cancer Invest 16:102-126, 1998
8. Dunphy FR, Spitzer G, Buzdar AU, et al: Treatment of estrogen receptor negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol 8:1207-1216, 1990
9. Peters WP, Shpall EJ, Jones RB, et al: High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6:1368-1376, 1988
10. Williams SF, Mick R, Desser R, et al: High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer. J Clin Oncol 7:1824-1830, 1989
11. Antman K, Ayash L, Elias A, et al: A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy [see comments]. J Clin Oncol 10:102-110, 1992
12. Williams SF, Gilewski T, Mick R, et al: High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: Follow-up report. J Clin Oncol 10:1743-1747, 1992
13. Ghalie R, Richman CM, Adler SS, et al: Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation. J Clin Oncol 12:342-346, 1994
14. Klumpp TR, Mangan KF, Glenn LD, et al: Phase II pilot study of high-dose busulfan and CY followed by autologous BM or peripheral blood stem cell transplantation in patients with advanced chemosensitive breast cancer. Bone Marrow Transplant 11:337-339, 1993
15. Bitran JD, Samuels B, Klein L, et al: Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant 17:157-162, 1996
16. Demirer T, Buckner CD, Appelbaum FR, et al: High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer. Bone Marrow Transplant 17:769-774, 1996
17. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483-2489, 1995
18. Eder J, Antman K, Peters W, et al: High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. J Clin Oncol 4:1592-1597, 1986
19. Kennedy MJ, Beveridge RA, Rowley SD, et al: High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer. J Natl Cancer Inst 83:920-926, 1991
20. Saez RA, Slease RB, Selby GB, et al: Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma. South Med J 88:320-326, 1995
21. Antman KH, Rowlings PA, Vaughan WP, et al: High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 15:1870-1879, 1997
22. Wood W, Budman D, Korzun A, et al: Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast carcinoma. N Engl J Med 330:1253-1259, 1994
23. Peters WP, Ross M, Vredenburgh JJ, et al: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132-1143, 1993
24. Bearman SI, Vredenburgh JJ, Cagnoni PJ, et al: High-dose therapy with autologous hematopoietic progenitor cell support for patients with breast cancer who failed previous stem cell-supported therapy. Proc Annu Meet Am Soc Clin Oncol 16:A414, 1997 (abstr)
25. Ayash L, Elias A, Ibrahim J, et al: High-dose multimodality therapy with autologous stem cell support for stage IIIB breast cancer: The DFCI/BIH experience. Proc Annu Meet Am Soc Clin Oncol 16:A318, 1997 (abstr)
26. Adkins DR, Brown RA, Beck E, et al: Outcomes of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) in stage IIIB inflammatory breast cancer (IBC). Proc Annu Meet Am Soc Clin Oncol 16:A360, 1997 (abstr)
27. Hann D, Jacobsen P, Martin S, et al: Quality of life following bone marrow transplantation for breast cancer: A comparative study. Bone Marrow Transplant 19:257-264, 1997
28. McQuellon R, Craven B, Russel G, et al: Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant 18:579-584, 1996
29. Larsen J, Gardulf A, Nordstrom G, et al: Health-related quality of life in women with breast cancer undergoing autologous stem-cell transplantation. Cancer Nurs 19:368-375, 1996
30. Winer E, Gold D, Lees J, et al: Quality of life following high dose chemotherapy with autologous bone marrow support in patients with metastatic breast cancer. Proc Annu Meet Am Soc Clin Oncol 10:A122, 1991 (abstr)
31. Winer E, Gold D, Affronti M, et al: Quality of life and psychosocial functioning in patients with metastatic breast cancer treated with high-dose chemotherapy and autologous bone marrow transplant. Proc Annu Meet Am Soc Clin Oncol 9:A1177, 1990 (abstr)
32. McQuellon R, Hoffman S, Hurd D, et al: Health-related quality of life before and after autologous bone marrow transplantation for breast cancer. Proc Annu Meet Am Soc Clin Oncol 13:A1612, 1994 (abstr)
33. Hillner B, Smith T, Desch C: Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. JAMA 267:2055-2067, 1992
34. Peters W, Rogers M: Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer. N Engl J Med 330:473-477, 1994
35. Lucey C, Westphal J: New approach to administrative medical decision-making: Evidence-based medicine using high dose chemotherapy/bone marrow transplant for breast cancer. South Med J 91:196-201, 1998